Literature DB >> 33567618

The Role of Necroptosis: Biological Relevance and Its Involvement in Cancer.

Laura Della Torre1,2, Angela Nebbioso1, Hendrik G Stunnenberg2,3, Joost H A Martens2, Vincenzo Carafa1, Lucia Altucci1.   

Abstract

Regulated cell death mechanisms are essential for the maintenance of cellular homeostasis. Evasion of cell death is one of the most important hallmarks of cancer. Necroptosis is a caspase independent form of regulated cell death, investigated as a novel therapeutic strategy to eradicate apoptosis resistant cancer cells. The process can be triggered by a variety of stimuli and is controlled by the activation of RIP kinases family as well as MLKL. The well-studied executor, RIPK1, is able to modulate key cellular events through the interaction with several proteins, acting as strategic crossroads of several molecular pathways. Little evidence is reported about its involvement in tumorigenesis. In this review, we summarize current studies on the biological relevance of necroptosis, its contradictory role in cancer and its function in cell fate control. Targeting necroptosis might be a novel therapeutic intervention strategy in anticancer therapies as a pharmacologically controllable event.

Entities:  

Keywords:  RIPK1; RIPK1 mutations; cancer; necroptosis

Year:  2021        PMID: 33567618      PMCID: PMC7914991          DOI: 10.3390/cancers13040684

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  111 in total

1.  Positive and negative phosphorylation regulates RIP1- and RIP3-induced programmed necrosis.

Authors:  Thomas McQuade; Youngsik Cho; Francis Ka-Ming Chan
Journal:  Biochem J       Date:  2013-12-15       Impact factor: 3.857

Review 2.  Necroptosis in cancer: An angel or a demon?

Authors:  Tianzhen Wang; Yinji Jin; Weiwei Yang; Lei Zhang; Xiaoming Jin; Xi Liu; Yan He; Xiaobo Li
Journal:  Tumour Biol       Date:  2017-06

Review 3.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

4.  RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis.

Authors:  Etienne Meylan; Fabio Martinon; Margot Thome; Michael Gschwendt; Jürg Tschopp
Journal:  EMBO Rep       Date:  2002-11-21       Impact factor: 8.807

5.  Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation.

Authors:  Hongxiu Li; Masayuki Kobayashi; Marzenna Blonska; Yun You; Xin Lin
Journal:  J Biol Chem       Date:  2006-03-16       Impact factor: 5.157

6.  Absence of RIPK3 predicts necroptosis resistance in malignant melanoma.

Authors:  P Geserick; J Wang; R Schilling; S Horn; P A Harris; J Bertin; P J Gough; M Feoktistova; M Leverkus
Journal:  Cell Death Dis       Date:  2015-09-10       Impact factor: 8.469

7.  Low expression of mixed lineage kinase domain-like protein is associated with poor prognosis in ovarian cancer patients.

Authors:  Ling He; Kuan Peng; Yizhi Liu; Jing Xiong; Fu-Fan Zhu
Journal:  Onco Targets Ther       Date:  2013-10-30       Impact factor: 4.147

8.  K63-linked ubiquitination regulates RIPK1 kinase activity to prevent cell death during embryogenesis and inflammation.

Authors:  Yong Tang; Hailin Tu; Jie Zhang; Xueqiang Zhao; Yini Wang; Jun Qin; Xin Lin
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

9.  Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease.

Authors:  Cornelis Blauwendraat; Xylena Reed; Demis A Kia; Ziv Gan-Or; Suzanne Lesage; Lasse Pihlstrøm; Rita Guerreiro; J Raphael Gibbs; Marya Sabir; Sarah Ahmed; Jinhui Ding; Roy N Alcalay; Sharon Hassin-Baer; Alan M Pittman; Janet Brooks; Connor Edsall; Dena G Hernandez; Sun Ju Chung; Stefano Goldwurm; Mathias Toft; Claudia Schulte; Jose Bras; Nicholas W Wood; Alexis Brice; Huw R Morris; Sonja W Scholz; Mike A Nalls; Andrew B Singleton; Mark R Cookson
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

10.  Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data.

Authors:  Nameeta Shah; Michael Lankerovich; Hwahyung Lee; Jae-Geun Yoon; Brett Schroeder; Greg Foltz
Journal:  BMC Genomics       Date:  2013-11-22       Impact factor: 3.969

View more
  9 in total

Review 1.  The Achilles' heel of cancer: targeting tumors via lysosome-induced immunogenic cell death.

Authors:  Taritsa Iulianna; Neote Kuldeep; Fossel Eric
Journal:  Cell Death Dis       Date:  2022-05-30       Impact factor: 9.685

2.  The Identification of Necroptosis-Related Subtypes, the Construction of a Prognostic Model, and the Characterization of the Tumor Microenvironment in Gliomas.

Authors:  Yueyang Ba; Jiahao Su; Shuangqi Gao; Zhi Liao; Zhimin Wu; Chengan Cao; Chaofeng Liang; Jin Gong; Ying Guo
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

3.  Construction and Validation of a Necroptosis-Related Gene Signature for Predicting Prognosis and Tumor Microenvironment of Pancreatic Cancer.

Authors:  Cheng Ding; ZhangPing Yu; JiQiao Zhu; XianLiang Li; MengHua Dai
Journal:  Dis Markers       Date:  2022-06-14       Impact factor: 3.464

4.  The potential role of necroptosis in clinical diseases (Review).

Authors:  Wenli Dai; Jin Cheng; Xi Leng; Xiaoqing Hu; Yingfang Ao
Journal:  Int J Mol Med       Date:  2021-03-31       Impact factor: 4.101

5.  Controlled Decompression Attenuates Compressive Injury following Traumatic Brain Injury via TREK-1-Mediated Inhibition of Necroptosis and Neuroinflammation.

Authors:  Tao Chen; Xiao Qian; Jie Zhu; Li-Kun Yang; Yu-Hai Wang
Journal:  Oxid Med Cell Longev       Date:  2021-11-08       Impact factor: 6.543

6.  Stem Cell Factor SOX9 Interacts with a Cell Death Regulator RIPK1 and Results in Escape of Cancer Stem Cell Death.

Authors:  Mijung Oh; Chaeyeon Son; Seung Bae Rho; Minjeong Kim; Kyoungsook Park; Sang Yong Song
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

7.  A Novel Approach: Combining Prognostic Models and Network Pharmacology to Target Breast Cancer Necroptosis-Associated Genes.

Authors:  Congzhi Yan; Conghui Liu; Zhixuan Wu; Yinwei Dai; Erjie Xia; Wenjing Hu; Xuanxuan Dai
Journal:  Front Genet       Date:  2022-08-22       Impact factor: 4.772

8.  Mitochondrion-Mediated Cell Death through Erk1-Alox5 Independent of Caspase-9 Signaling.

Authors:  Min Chen; Lei Wang; Min Li; Marietta M Budai; Jin Wang
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

Review 9.  Does Cancer Biology Rely on Parrondo's Principles?

Authors:  Jean-Pascal Capp; Aurora M Nedelcu; Antoine M Dujon; Benjamin Roche; Francesco Catania; Beata Ujvari; Catherine Alix-Panabières; Frédéric Thomas
Journal:  Cancers (Basel)       Date:  2021-05-03       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.